Relay Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Relay Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Relay Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$96.4M, a 31% decline year-over-year.
  • Relay Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$380M, a 7.36% decline year-over-year.
  • Relay Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$373M, a 24.6% decline from 2022.
  • Relay Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$299M, a 17.9% increase from 2021.
  • Relay Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$365M, a 554% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$373M -$73.7M -24.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 -$299M +$65.4M +17.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 -$365M -$309M -554% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 -$55.8M +$28.3M +33.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$84M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.